Not recruiting
Rectal cancer
Not recruitingInvestigationalNo placebo
Study of SGM-101 Fluorescent Imaging for Detection of Early Rectal Cancer in Patients with Suspected T1 Adenocarcinoma or High-Grade Dysplasia
InvestigationalNo placebo
- Disease:Rectal cancer
- Substances:Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
